| 摘要: |
| 目的：博来霉素（Bleomycin，BLM）是目前用于治疗多种头颈癌等癌症的药物之一，但会产生一系列副作用，例如肺纤维化（Pulmonary Fibrosis，PF），这大大降低了患者的生活质量。藻蓝蛋白（Phycocyanin，PC）作为一种色素蛋白对包括PF在内的多种疾病具有调节作用。研究发现，慢性肠道疾病通常伴有肺部疾病，患者的肠道菌群会发生紊乱。针对上述线索，本文研究了PC对BLM诱导的PF小鼠肠道菌群的影响。
方法：通过尾静脉将BLM注入小鼠体内，以构建肺纤维化模型。然后通过高通量生物16SrRNA基因测序技术，分析了PC对BLM引起的PF小鼠肠道菌群的影响。
结果：PC降低了BLM诱导的PF程度并调节了小鼠的肠道菌群。通过尾静脉注射BLM后，小鼠肺部受到损伤，肠道菌群发生紊乱。口服藻蓝蛋白干预后，小鼠的肺组织切片显示其胶原蛋白沉积减少，肺泡间隔和炎性细胞浸润减少，小鼠PF程度减轻。此时，小鼠肠道菌群中Alistipes、Lachnospiraceae等有益菌的丰度增加，Rikenella等的有害菌的丰度降低，肠道菌群趋于正常。
结论：我们推测PC可以通过增加肠道中有益细菌的数量并减少肠道中有害细菌的数量来调节尾静脉注射BLM引起的肠道菌群失调，从而降低小鼠的PF程度。 |
| 关键词: 藻蓝蛋白 博来霉素 肺纤维化小鼠 肠道菌群 |
| DOI： |
| 分类号: |
| 基金项目:烟台市重点研发项目和国家重点研发项目 |
|
| The effect of phycocyanin on the intestinal flora of mice with bleomycin-induced pulmonary fibrosis |
|
Zang Fan1, Li Wenjun2, Qin Song2
|
|
1.Yantai University;2.Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences
|
| Abstract: |
| Objective: Bleomycin (BLM) is one of the drugs currently used to treat a variety of cancers, but it will produce a series of side effects, such as pulmonary fibrosis (PF). This greatly reduces the life quality of patients. Phycocyanin (PC), as a type of pigment protein, has been proven to be effective for many diseases such as PF. Studies have found that chronic intestinal diseases are usually accompanied by lung diseases, and the intestinal flora of patients will be disordered. In response to the above clues, this article studied the effect of PC on the intestinal flora of mice with BLM-induced PF.
Design: BLM was injected into mice through the tail vein to construct a pulmonary fibrosis model. Then combined with high-throughput sequencing technology, the influence of PC on the intestinal flora of mice with pulmonary fibrosis caused by BLM was analyzed.
Results: PC reduced the degree of PF induced by BLM and regulated the intestinal flora of mice. After mice were injected with BLM through the tail vein, their lungs were injured and the intestinal flora was disturbed. Through oral phycocyanin intervention, lung tissue sections of mice showed improvement in pulmonary fibrosis, decreased collagen deposition, and reduced alveolar septum and inflammatory cell infiltration. At this time, the abundance of beneficial bacteria, such as Alipites and Lachnospiraceae in the feces of mice increased, the abundance of harmful bacteria such as Rickerella decreased, and the intestinal flora tended to be normal.
Conclusion: We speculate that PC can adjust the intestinal flora disorder caused by intravenous BLM injection by increasing the abundance of beneficial bacteria and reducing the abundance of harmful bacteria in the intestines, thereby reducing the degree of PF in mice. |
| Key words: Phycocyanin Bleomycin Pulmonary fibrosis mice Intestinal flora |